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Abstract. The study we have performed was conducted during 2006-2007, on a number of 16 
horses, aged between 4 and 18 years, belonging to following breeds: Quarter Horse, Dutch 
Warmblood, Thoroughbred, Passo Fino, Hanoverian, Selle Française. There is no direct correlation 
between the age and incidence of this degenerative process.   
The therapy of this disease has sought the combination between medical treatment and 
recovery one, and surgical treatment when the results of medical treatment and the recovery were 
negative.  
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INTRODUCTION 
 
This study consists of a detailed approach of therapeutic protocol in navicular disease. 
Navicular disease is a chronic degenerative affection of podotrochlear bursa and navicular 
bone. It has a complex pathogenesis, in which the following anatomical structures might be 
involved: navicular bone, the vascularization of the foot, the distal interphalangian joint, the 
ligaments of navicular bone and the tendon of the deep digital flexor.  
The study has been conducted at Tufts Cummings School of Veterinary Medicine, 
Massachusetts, U.S.A., on 16 horses, out of which 7 were presented for a consult in 2006 and 
9 in 2007. The age of the horses is between 4 and 18 years. There is no direct correlation 
between the age and incidence of this degenerative process.  
The horses are belonging to different breeds, both performance and leisure -Quarter 
Horse, Dutch Warmblood, Thoroughbred, Passo Fino, Hanoverian, Selle Française, with the 
highest frequency in Quarter Horse and Dutch Warmblood.  We notice here that our data 
correspond from this point of view to the ones mentioned in the literature.  
 
MATERIALS AND METHODS 
 
Therapy of this disorder aims combining medical treatment with the recovery, and 
when results are negative the surgical treatment is used.  
The medical treatment 
The main objectives of the medical treatment are the administration of:  
• Nonsteroidal antiinflamatory drugs - Phenylbutazone;   
• Corticosteroids; 
• Hyaluronic acid; 
• Condroprotective substances - polysulfated glycosaminoglycan (PSGAG), 
glucosamine, chondroitin sulfate, etc. 
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• Vasoactive medication - Isoxsuprine, pentoxyfylline, etc. 
• Interleukin-1 Receptor Antagonist Protein (IRAP). 
Nonsteroidal Antiinflamatory Drugs 
This group of drugs has two main effects, the antialgic and anticoagulant effect. In this 
class, the most commonly used drugs are:  
 flunixin meglumine 1,1 mg/kg, IV, twice a day; 
 phenilbutazone 2,2 mg/kg, per os, twice a day; 
Treatment will last at least one week, the best results being achieved through the 
combination of the two drugs. In our case we used only phenilbutazone. Particular attention 
will be given to the side effects of these products, since a long period of administration favors 
the emergence of gastric ulcers and renal failure. For this reason it is recommended 
conducting a preventive treatment in this respect.  
Corticosteroids 
Corticosteroids are used for their anti-inflammatory effect. They can be administered 
orally or intra-articular, the latter having the greatest efficiency. The product we used is Depo 
Medrol®, containing 20 mg / ml of methylprednisolone acetate.  
The dose varies between 40 and 120 mg per joint, depending on the size of the animal 
and the size of the synovial bursa. In navicular disease we used 60 mg per joint.  
Hyaluronic Acid 
The product we used is called Hylartin®, and it contains 10 mg/ml sodium 
hyaluronate. Upjohn Company is producing. This product is administered intra-articular in 
conditions of perfect sterility, the recommended dose being 20 mg per joint. The treatment is 
repeated weekly with a total of three or four administrations. 
 Another product based on hyaluronic acid is Legend® (hyaluronate sodium). This is 
the only drug of this class that can be administered intravenously. The dose is 40 
mg/administration, once a week with three consecutive repetitions. 
Condroprotective Substances 
In this group are included polysulfated glycosaminoglycan (PSGAG), glucosamine, 
chondroitin sulfate, and other substances. PSGAG have a protective role of cartilage more 
than a curative one. They are used more prophylactically to prevent the loss of cartilage 
substance.  
The product we are used is Adequan® I.M. and has as active substance polysulfated 
glycosaminoglycan .The therapeutic protocol consists of administering a dose of 500 mg 
intramuscular at five days interval with 6-8 repetitions. 
Vasoactive Medications 
In this substance category belong isoxsuprin and pentoxyfylin. In a few cases we used 
isoxsuprin. Isoxsuprin has as main effect the relaxation of smooth muscles of blood vessels. It 
stimulates the beta-adrenergic receptors. It is demonstrated that in navicular disease 
isoxsuprin lead to a significant increase in local temperature, which will produce 
vasodilatation. This supports the ischemic theory of this disease (15).  
In large doses isoxsuprin induces a decrease of blood viscosity and reduces the platelet 
aggregation. 
The recommended dose is 0,6 - 0,66 mg/kg, per os, twice a day, for 21 days. Then 
follows a course of 14 days with one administration a day and after 7 days with the daily 
management. Each tablet contains 20 mg of active substance.  
Interleukin-1Receptor Antagonist Protein - IRAP 
 The principle of this treatment consists of blocking the bonding between interleukin l 
(IL-1) and tissue, thus preventing the negative consequences of this action. IL-1 is a cytokine 
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secreted by cells of the immune system, which plays an important role in regulating immune 
responses, crucial in intervening in the activation and suppression or orientation of these 
responses (10). In joint diseases, this cytokine accelerates destruction of articular cartilage.  
 This treatment protocol consists of harvesting a quantity of 20 ml of blood in syringes 
with an anticoagulant and specially treated glass balls that stimulate the production of protein 
antagonist. The sample is incubated at 370C for 24 hours and then is centrifuged for obtaining 
autologous serum, which contains protein receptor antagonist of interleukin-1. There will be 
three intra-articular administrations at one week interval. The recommended dose is 1-2 ml.  
The Surgical Treatment 
 Involves the fasciotomy of impair navicular ligament or the navicular suspensory 
ligament. If the results are not satisfactory the palmar digital nerves neurectomy is used. 
The Recovery Treatment 
The recovery treatment seeks to: 
• allow for rest period followed by a progressive resuming of the physical 
activity; 
• perform orthopedic shoeing; 
• undergo extracorporeal shock waves physiotherapy. 
The Rest Period 
 The rest interval should be customized for each animal and correlated with the degree 
of healing. Usual duration is 6 weeks. Resumption of physical activity is done gradually, with 
intervals of 5-10 minutes of exercises in circle, then by ridden horse. Every two weeks, this 
interval will be increased by one minute, until you reach the two 30 minutes a day, of which 
10 minute will trap. If the animal can perform these exercises without difficulty, it will be 
added one minute of canter, every 30 minutes. This increase in length is made every 10 days, 
until it reaches 30-35 minutes.   
The Orthopedic Shoeing  
 This operation aims to ensure the medio-lateral as well as the cranio-caudal balance of 
the hooves. Oval aluminum horseshoes are used. These can be simple oval ones or horseshoes 
with a support for the frog. For decompressing the navicular region, the orthopedic pads are 
used, which can be made of rubber or leather, the latter being the better. They have different 
degrees of inclination, in the treatment of navicular syndrome are indicated the ones with the 
degree of tilt between 1-30. The adjustment depends on their results from X-ray examination.  
Focalized Extracorporeal Shock Waves Therapy  
 It is a non-invasive method, which uses a pressure generated in a fluid environment 
that can be concentrated on the affected region. During the physiotherapy, horse adopts a 
staying attitude being slightly sedated. Between 1000 and 2000 pulsations are used, at a level 
of energy that will not exceed 0.5 mJ/mm2 for 10-20 minutes. Number of sessions depends on 
the location and severity of lesion. In soft tissue conditions a minimum of two sessions is 
required, and for bone disorders a session is sufficient (3). 
  To avoid damage to adjacent tissue, this treatment may be done under radiographic or 
ultrasound guidance.  
 
RESULTS AND DISCUSSIONS 
 
Medical treatment consisted of using the: 
 Non steroidian anti-inflammatory drugs: phenylbutazone- per os, the dose of 2.2 
mg/kg/ day, for five days minimum. Phenylbutazone was used in the treatment of 13 
cases.  
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 Corticosteroids: methylprednisolone acetate (Depo-Medrol®), intraarticular, 60 mg 
per joint. Number of administration depends on the degree of recovery of the animal. 
Methylprednisolone acetate was administered intraarticular to 9 horses.  
 Hyaluronic acid - Hylartin® (sodium hyaluronate), intraarticular,  20 mg per joint, 3-4 
administrations at one week interval. Hyaluronic acid administered by intra-articular 
way, was used in 6 horses.  
 Hyaluronic acid Legend® (sodium hyaluronate), the only product of this class of 
drugs that can be administered intravenously. The dose is 40 mg/administration, once 
a week with three consecutive repetitions. This product, with intravenous 
administration, was used in 5 cases. 
  Polysulfated glycosaminoglycan (Adequan® I.M.), intramuscularly in dose of 500 mg 
per administration, at five days, with 6-8 repetitions. This product has been 
administered to 4 horses. 
  Interleukin-1 Recepetor Antagonist Protein-IRAP. There are three intra-articular 
administrations of 1-2 ml each at an interval of seven days. IRAP therapy was used in 
3 cases.  
The recovery treatment seeked to:  
 Provide an adequate period of rest - more than six weeks, to all patients taken in the 
study;  
 Perform orthopedic shoeing in 12 cases; 
 Undergo the focalized extracorporeal shock wave therapy with a number a pulsations 
between 1000 and 2000, at a level of energy that will not exceed 0.5 mJ/mm2 for 10-
20 minutes. For bone disorders a session is sufficient and in soft tissue conditions a 
minimum of two sessions is required. This method was used in 7 cases out of 16. 
The surgical treatment was used only in one case and consisted of digital palmar nerves 
neurectomy of the affected limb. 
 
CONCLUSIONS 
 
1. Our studies show that there is no direct correlation between the occurrence of this 
disease, age and sex of the animal, our caseload being represented by the horses of both sexes, 
aged between 4 and 18 years. 
2. Conditions encountered at the level of the navicular bone are: inflammatory 
processes, sclerosis and navicular bone degeneration, small sesamoid bone fracture, pedal 
osteitis, impair ligament and collateral ligaments of the small sesamoid desmitis and deep 
digital flexor tendinitis, at the insertion place on small sesamoid bone. 
3. In the studied cases, navicular disease therapy pursued two main objectives:  
 Offering a medical treatment and a surgical one; 
 Ensuring a recovery treatment. 
The medical treatment consisted of the administration of hyaluronic acid intra-
articular as well as intravenous, corticosteroids (methylprednisolone) intra-articular, the non-
steroidian anti-inflammatory drugs (phenylbutazone) per os, but also the IRAP procedure. In 
one case the palmar digital nerves neurectomy was performed. The recovery treatment was 
achieved by performing extracorporeal shock wave physiotherapy, by applying orthopedic 
horseshoes and by granting a period of rest, individualized for each case.   
4. Navicular disease remains a controversial topic, in which prevention and treatment, 
the method of shoeing and management of physical activity of the horse has a major role.  
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